Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Neoplasms 3 Breast Neoplasms 3 Prostatic Neoplasms 2 Neoplasms, Nerve Tissue 2 Glioma 2 Glioblastoma 2 Colorectal Neoplasms 2 Carcinoma, Hepatocellular 2 Brain Neoplasms 2 Neoplasm Metastasis 1 Liver Neoplasms 1 Fibrosis 1 Colon Cancer Liver Metastasis 1 Carcinoma, Pancreatic Ductal 1 Ascites 1 Abdominal Neoplasms 1 Abdominal Injuries 1

Interventions

Propofol 2 Dexmedetomidine 2 serotonin adipinate 1 contrast agent BR1 1 Therapeutics 1 Surgical Procedures, Operative 1 Sevoflurane 1 Serotonin 1 Ropivacaine 1 Paclitaxel 1 Nitrous Oxide 1 Metastasectomy 1 Lidocaine 1 Iohexol 1 Imatinib Mesylate 1 Glycopyrrolate 1 Food, Formulated 1 Fluorouracil 1 FS 069 1 Enoxaparin 1 Embolization, Therapeutic 1 Drug Therapy 1 Doxorubicin 1 Dietary Supplements 1 Cytoreduction Surgical Procedures 1 Continuous Positive Airway Pressure 1 Cisplatin 1 Cell Count 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Abdominal Neoplasms × contrast agent BR1 × Clear all

NCT07113808 2025-12-08

CEUS

The Children's Hospital of Zhejiang University School of Medicine

Abdominal Injuries, Abdominal Neoplasms, Ascites

Data powered by HemOnc (CC BY 4.0) Colophon ⚡